Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. Am J Hematol 2017 Oct;92(10):E610-E611
Date
07/13/2017Pubmed ID
28699171DOI
10.1002/ajh.24850Scopus ID
2-s2.0-85026445343 (requires institutional sign-in at Scopus site) 7 CitationsAuthor List
Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NNAuthors
William R. Drobyski MD Professor in the Medicine department at Medical College of WisconsinMehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin
J. Douglas Rizzo MD, MS Director, Center Associate Director, Professor in the Medicine department at Medical College of Wisconsin
Wael Saber MD, MS Professor in the Medicine department at Medical College of Wisconsin
Nirav N. Shah MD Professor in the Medicine department at Medical College of Wisconsin
Bronwen E. Shaw MBChB, PhD Center Director, Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Acute DiseaseAdult
Allografts
Disease-Free Survival
Gastrointestinal Diseases
Graft vs Host Disease
Hematologic Neoplasms
Humans
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation
Survival Rate
alpha 1-Antitrypsin